FY24 consensus $7.74. Narrows FY24 revenue view to $63.6B-$64.1B from $63.4B-$64.4B, consensus $64.15B.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Notable companies reporting before tomorrow’s open
- Merck & Company (MRK) Q3 Earnings Cheat Sheet
- Options Volatility and Implied Earnings Moves This Week, October 28 – November 01, 2024
- Merck, Moderna launch Phase 3 trial evaluating adjuvant V940, Keytruda combo
- Merck price target lowered to $130 from $140 at Citi